<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title42.html">
                                    Title 42
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/42CFR82.html">Part 82
                                </a><span>&nbsp/&nbsp<span>
                                Sec.  82.26  How will NIOSH report dose reconstruction results?
                            </h3>
                            <p class="depth1"><em>(a)</em> NIOSH will provide dose reconstruction results to the claimant,  DOL, and DOE in a report: ``NIOSH Report of Dose Reconstruction under  EEOICPA.'' The report itself will not provide information on probability  of causation, which DOL must calculate to determine a recommended  decision on the claim.</p><p class="depth1"><em>(b)</em> The report will include the following information, as relevant:</p><p class="depth2"><em>(1)</em> Annual dose estimates (or a fraction thereof) related to covered  employment for each year from the date of initial radiation exposure at  a covered facility to the date of cancer diagnosis;</p><p class="depth2"><em>(2)</em> Separate dose estimates for acute and chronic exposures,  different types of ionizing radiation, and internal and external doses,  providing internal dose information only for the organ or tissue  relevant to the primary cancer site(s) established in the claim;</p><p class="depth2"><em>(3)</em> Uncertainty distributions associated with each dose estimated,  as necessary;</p><p class="depth2"><em>(4)</em> Explanation of each type of dose estimate included in terms of  its relevance for estimating probability of causation;</p><p class="depth2"><em>(5)</em> Identification of any information provided by the claimant  relevant to dose estimation that NIOSH decided to omit from the basis  for dose reconstruction, justification for the decision, and if  possible, a quantitative estimate of the effect of the omission on the  dose reconstruction results; and</p><p class="depth2"><em>(6)</em> A summary and explanation of information and methods applied to  produce the dose reconstruction estimates, including any factual  findings and the evidence upon which those findings are based.</p><p class="depth1"><em>(c)</em> As provided under Sec.  82.10(l), NIOSH staff will conduct a  closing interview with claimants to explain the dose reconstruction  report.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
